Collection and Distribution of Samples From Healthy Donors for In Vitro Research at NCI-Frederick
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 1,200
- 试验地点
- 2
- 主要终点
- Establish a centralized repository for the collection and distribution ofsamples
研究概览
简要总结
Background
-NCI-Frederick scientists performing in vitro studies involving human specimens have a need for a reliable and consistent source of samples which protects the donor from research risks.
Objective
-The purpose of this protocol is to establish a centralized repository for the collection and distribution of samples (either blood, buccal mucosal cells, semen, urine, or nail clippings) from paid, healthy volunteer donors for in vitro research conducted by NIH investigators located at NCI-Frederick and Ft. Detrick. Research will include, but are not limited to, genotype analysis, immune function studies, drug screening, vaccine development, method development, quality control testing of reagents, and propagation of infectious agents, including HIV.
Eligibility:
Healthy NCI-Frederick employees and other NIH staff located at Ft. Detrick will be recruited. Potential donors will be excluded if screening indicates exposure to HIV, HTLV, Hepatitis C or Hepatitis B virus infection.
Study Design:
Investigators requesting to participate to the Research Donor Program (RDP) by receiving samples for research use will be required to submit a written memo of request, briefly describing the nature of the research and providing assurance that samples provided through this protocol will be used solely for in vitro research.
These Investigators will receive samples that will be either anonymous or coded, depending on the specific need.
Codes will be securely maintained and under no circumstances will donor identity be released to Investigators.
Donors will receive financial compensation for their time, discomfort and inconvenience according to an established schedule; compensation for blood donation is based on the volume donated.
详细描述
Background
-NCI-Frederick scientists performing in vitro studies involving human specimens have a need for a reliable and consistent source of samples which protects the donor from research risks.
Objective
-The purpose of this protocol is to establish a centralized repository for the collection and distribution of samples (either blood, buccal mucosal cells, semen, urine, feces, nasopharyngeal swabs, or nail clippings) from paid, healthy volunteer donors for in vitro research conducted by NIH investigators located at NCI-Frederick and Ft. Detrick. Research will include, but are not limited to, genotype analysis, immune function studies, drug screening, vaccine development, method development, quality control testing of reagents, and propagation of infectious agents, including HIV.
Eligibility:
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •INCLUSION CRITERIA:
- •Individuals must meet the following eligibility criteria to be entered into the RDP donor pool, as follows:
- •Age 18 or older.
- •Weight of 110 lb or greater.
- •All subjects must have the ability and agree to participate fully and comply with the procedures of the protocol and provide informed consent.
- •Registration for participation in semen donation is limited to males currently enrolled in the donor pool.
- •Subjects must be NCI Frederick Employees
排除标准
- •Individuals with any of the following will be excluded from the donor pool:
- •History of chronic illness that might increase the risks associated with phlebotomy, including but not limited to heart, lung, or kidney disease
- •Current acute illness.
- •History of clotting disorders.
- •Current medications which might increase the risks associated with phlebotomy.
- •History of syncope or other difficulty with venipuncture.
- •Anemia, as determined by hematocrit or hemoglobin.
- •Hematocrit Acceptable range for males: 40-51 percent.
- •Hematocrit Acceptable range for females: 34-46 percent.
- •Hemoglobin Acceptable range for males: 12.5-17.0 g/dl
- •Hemoglobin Acceptable range for females: 11.5-15.2 g/dl
- •Positive blood test for exposure to HIV-1, HIV-2, HTLV-1, HTLV-2, or HCV or for HBV surface antigens.
- •Individuals whose activities or conditions place them at high risk of HIV infection are asked not to donate.
- •Males who qualify for participation in the donor pool will be excluded from participation in semen donation if they have knowingly had any injury, infection, or treatment performed that renders them incapable of producing sperm.
- •Pregnancy: Pregnant women will not be allowed to enroll in this study because there is no benefit.
研究组 & 干预措施
1/ single cohort
Healthy NCI Frederick Cancer Research and Development Center employees
结局指标
主要结局
Establish a centralized repository for the collection and distribution ofsamples
时间窗: Ongoing
Collection of biospecimens
次要结局
未报告次要终点